We help Support at Home-approved families find care.
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Keeping older people healthy

New research on ways to keep older people healthy for longer will be discussed this Thursday in Melbourne. The ASPirin in Reducing Events in the Elderly (ASPREE) study, which aims to determine whether a daily dose of aspirin can delay the onset of illness, will be evaluated.

Posted
by Carey Heart

New research on ways to keep older people healthy for longer will be discussed this Thursday in Melbourne.

The ASPirin in Reducing Events in the Elderly (ASPREE) study, which aims to determine whether a daily dose of aspirin can delay the onset of illness, will be evaluated.

ASPREE principal investigator, Professor John McNeil, from the Monash Department of Epidemiology and Preventive Medicine, will discuss what the largest primary prevention study in healthy older people in the world will mean for Victoria and Australia.

“Australians are living longer. If present trends continue, up to 50% of babies born today will live to be more than 100 years old, so the ability to remain healthy is a priority,” Professor McNeil explained.

ASPREE will determine aspirin’s potential for reducing the risk of heart attack, stroke, dementia and certain cancers in people aged 70 years and over. It will also determine if potential health benefits outweigh the risks of regular aspirin in this age group.

Executive officer of the ASPREE clinical trial and director of the ancillary study ASPREE Healthy Ageing Biobank, Associate Professor Robyn Woods, will speak about the study’s progress and achievements.

“ASPREE has become a platform for many sub-studies to provide the first comprehensive picture of ageing in Australia,” Associate Professor Woods said.

“GPs will know whether aspirin promotes good health in later years. We will be able to identify medical and social issues affecting our ageing population and future researchers will be able to access a world-first ‘biobank’ to identify predictors of disease.

“What sets ASPREE apart is the study engages local GPs and community health networks and with this study we are taking medical research to the people rather than the other way around.”

The Monash Business Breakfast ‘ASPREE – a window on ageing’ will be held this Thursday from 7.15am at the Trilogy Room, Park Hyatt in east Melbourne. The event is free of charge and includes a full breakfast.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo